Financial Gravity Asset Management, Inc. Amgen Inc Transaction History

Financial Gravity Asset Management, Inc.

$506 Billion
Q3 2025

A detailed history of Financial Gravity Asset Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 51 shares of AMGN stock, worth $17,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$17,427

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$271.18 - $309.22 $13,830 - $15,770	51 New	51 $14.5 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $1,051 - $1,277	-4 Reduced 57.14%	3 $937,000
Q1 2024 Jun 26, 2024	SELL	$268.87 - $324.56 $1,075 - $1,298	-4 Reduced 36.36%	7 $1.96 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $8,066 - $9,736	-30 Reduced 46.15%	35 $9.72 Million
Q4 2023 Jun 26, 2024	SELL	$255.7 - $288.46 $6,136 - $6,923	-24 Reduced 68.57%	11 $3.32 Million

Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $34,984 - $43,433	-160 Reduced 71.11%	65 $17,000
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $3,642 - $4,307	-17 Reduced 7.02%	225 $6.05 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $4,741 - $5,779	-21 Reduced 7.98%	242 $4.2 Million
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $1.49 Million - $1.89 Million	-6,487 Reduced 96.1%	263 $14.2 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $339,383 - $382,762	-1,512 Reduced 18.3%	6,750 $9.41 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $1.01 Million - $1.13 Million	4,386 Added 113.16%	8,262 $8.07 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $136,824 - $151,363	-624 Reduced 13.87%	3,876 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $886,408 - $1.01 Million	4,457 Added 10365.12%	4,500 $2.04 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $212 - $248	-1 Reduced 2.27%	43 $213,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $1,635 - $1,813	-7 Reduced 13.73%	44 $244,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1,775 - $2,068	-8 Reduced 13.56%	51 $12.6 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $12,766 - $15,202	59 New	59 $13,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $92,970 - $114,087	-470 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $19,317 - $25,620	-106 Reduced 18.4%	470 $95,000
Q4 2019 Feb 28, 2020	SELL	$189.21 - $243.2 $49,005 - $62,988	-259 Reduced 31.02%	576 $251,000
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $35,518 - $42,558	-204 Reduced 19.63%	835 $162,000
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $36,840 - $43,185	-221 Reduced 17.54%	1,039 $191,000
Q1 2019 Apr 19, 2019	SELL	$180.87 - $203.88 $463,931 - $522,952	-2,565 Reduced 67.06%	1,260 $242,000
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $60,589 - $68,307	327 Added 9.35%	3,825 $720,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $11,789 - $13,242	71 Added 2.07%	3,498 $680,000
Q1 2018 May 23, 2018	BUY	$169.43 - $198.0 $580,636 - $678,546	3,427 New	3,427 $579,000

Others Institutions Holding AMGN

# of Institutions

3,276

Shares Held

428M

Call Options Held

6.17M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account

Financial Gravity Asset Management, Inc. Amgen Inc Transaction History